Transdermal permeability of N-acetyl-D-glucosamine

Pharmaceutical Development and Technology

Volumn 12, Issue 2, 2007, Pages 169-174

  Garner Jr , Solomon T ^a   Israel, Bridgette J ^a   Achmed, Hishamaldin ^a   Capomacchia, Anthony C ^a   Abney, Trina ^a   Azadi, Parastoo ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Glycosaminoglycan (GAG); N acetyl D glucosamine (NAG); Osteoarthritis; Skin permeation enhancers; Transdermal permeation

Indexed keywords

ALCOHOL; MYRISTIC ACID ISOPROPYL ESTER; N ACETYLGLUCOSAMINE; OLEIC ACID; PALMITIC ACID ISOPROPYL ESTER; PHOSPHATE;

ABSORPTION; ANIMAL TISSUE; ARTICLE; DIFFUSION; EVALUATION; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; SKIN;

ACETYLGLUCOSAMINE; ADJUVANTS, PHARMACEUTIC; ADMINISTRATION, CUTANEOUS; ANIMALS; BUFFERS; DIETARY SUPPLEMENTS; DIFFUSION; DIMETHYL SULFOXIDE; ETHANOL; GLUCOSAMINE; HYDROGEN-ION CONCENTRATION; MYRISTATES; OLEIC ACID; OSTEOARTHRITIS; PALMITATES; PERMEABILITY; PHOSPHATES; SKIN ABSORPTION; SNAKES; SOLVENTS;

EID: 34249007553     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450701212560     Document Type: Article

References (28)

1. Theodasakis, Jason; Fox, Barry; Adderly, Beverly. The Arthritis Cure 1st ed. St. Martin's Press: New York, 1997.
2. McAlindon, T.E.; LaValley, M.P.; Gulin, J.P.; Felson, D.T. Glucosamine and chondroitin for treatment of osteoarthritis: A systematic quality assessment and meta-analysis. JAMA. 2000, 283, 1469-1475.
3. Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT). National Center for Complementary and Alternative Medicine (NCCAM), and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). September 1999. (http://nccam.nih.gov/research/results/gait/qa.htm)
4. Merrick, J.M.; Roseman, S. Glucosamine metabolism. J. Biop. Chem. 1960, 5, 235-242.
5. Milewski, S. Glucosamine-6-phophate synthase. Biochim. Biophys. Acta 2002, 1597, 173-192.
6. Capomacchia, A.C.; Garner, S.T.; Beach, W.J. NSAID/ Glucosamine Mutual Prodrug and Uses Thereof. US Provisional Patent Application No. 60/560,128. 2004; Patent Application 235.00560201, Glucosamine and glucosamine/anti- inflammatory mutual prodrugs, compositions and methods, Capomacchia, AC; Garner, ST; Beach, WJ., 'Glucosamine; filed April 7, 2005.
7. Setnikar, I.; Giacchetti, C.; Zanolo, G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittel-Forschung 1986, 36 (4), 729-735.
8. Aghazadeh-Habashi, A.; Sattari, S.; Pasutto, F.; Jamali, F. Single dose pharmacokinetics and bioavailability of glucosamine in the rat. J. Pharm. Pharm. Sci. 2002, 5 (2), 181-184.
9. Setnikar, I.; Palumbo, R.; Canali, S.; Zanolo, G. Pharmacokinetics of glucosamine in man. Arzneimittel-Forschung 1993, 43 (10), 1109-1113.
10. Setnikar I; Rovati L C Absorption, distribution, metabolism and excretion of glucosamine sulfate: A review. Arzneimittel-Forschung 2001, 51 (9), 699-725.
11. Lamari, F.N.; Militsopoulou, M.; Mitropoulou, T.N.; Hjerpe, A.; Karamanos, N.K. Analysis of glycosaminoglycan-derived disaccharides in biological samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans. Biomed. Chromatogr. 2002, 16, 95-102.
12. Optimal Settings for Pulsed Amperometric Detection of Carbohydrates Using the Dionex ED40 Electrochemical Detector. Technical Note 21, Dionex Corp., Sunnyvale, CA, USA.
13. Clarke, A.P.; Jandik, P.; Rocklin, R.D.; Liu, Y.; Avdalovic, N. An integrated amperometry waveform for the direct, sensitive detection of amino acids and amino sugars following anion exchange chromatography. Anal. Chem. 1999, 71, 2774-2781.
14. Campo, G.M.; Campo, S.; Ferlazzo, A.M.; Vinci, R.; Calatroni, A. Improved high-performance liquid chromatographic method to estimate amino sugars and its application to glycosaminoglycan determination in plasma and serum, J. Chromatogr. B 2001, 765, 151-160.
15. LaCourse, W.R. Pulsed Electrochemical Detection in High-Performance Liquid Chromatography. John Wiley & Sons Inc.: New York, 1997.
16. Itoh, T.; Xia, J.; Magavi R.; Nishihata, T.; Rytting, J.H. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: Comparison with human skin. Pharm. Res. 1990, 7, 1042-1047
17. Bach, M.; Lipppold, B.C. Percutaneous penetration enhancement and its quantification. Eur. J. Pharm. Biopharm. 1998, 46, 1-13. Guidance for Indusry:
18. Hadgraft, J.; Guy, R.H.; Feasibility assessment in topical and transdermal delivery: Mathematical models and in vitro studies. Transdermal Drug Delivery, 2nd ed. Marcel Dekker, Inc.: New York, 2003, 1-23.
19. Bernacki, R.J.; Sharma, M.; Porter, N.K.; Rustum, Y.; Paul, B.; Korytnyk, W. Biochemical characteristics, metabolism and antitumor activity of several acetylated hexosamines. J. Supramol. Struct. 1977, 7, 235-250.
20. Xudong Yuan and A.C. Capomacchia. The binary eutectic of NSAIDs and two-phase liquid system for enhanced membrane permeation. Pharm. Dev. Technol. 2005, 1, 1-10.
21. Franz, T.J.; Lehman, P.A.; Kagy, M.K. Dimethyl sulfoxide. Percutaneous Enhancers; Smith, E.W.; Maibach, H.I. Eds.; CRC Press, Inc.: Boca Raton, FL, 1995, 112-127.
22. Barry, B.W. Lipid-protein-patitioning theory of skin penetration enhancement. J. Control. Release 1991, 15, 237-248.
23. Williams, A.C.; Barry, B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 1992, 9, 305-353.
24. Sinha, V.R.; and Kaur, M.P. Permeation enhancers for transdermal drug delivery. Drug Dev. Ind. Pharm. 2000, 26, 1131-1140.
25. Berner, B.; Liu, P. Alcohols, percutaneous penetration enhancers. Alcohols. Smith, E.W.; Maibach, H.I. Eds.: CRC Press: Boca Raton, FL, 1995, 45-60.
26. Kurihara-Bergstrom, T.; Flynn, G.L.; Higuchi, W.I. Physicochemical study of percutaneous absorption enhancement by dimethyl sulfoxide: Dimethyl sulfoxide mediation of vidarabine (ara-A) permeation of hairless mouse skin. J. Inv. Derma., 1987, 89, 274-280.
27. Magnusson, B.M.; Walters, K.A.; Roberts, M.S. Veterinary drug delivery: Potential for skin penetration enhancement. Adv. Drug Del. Rev., 2001, 50, 205-227.
28. Kanwischer, M.; Kim, S.-Y.; Bian, S.; Kwon, A.E.; Kim, J.S.; and Kim, D.-D. Evaluation of the physicochemical stability and skin permeation of glucosamine salts. Drug Dev. Ind. Pharm. 2005, 31 (1), 91-97.